Q3751766 (Q3751766): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes) |
(Created claim: summary (P836): The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking int...) |
||||||||||||||
| Property / summary | |||||||||||||||
The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English) | |||||||||||||||
| Property / summary: The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English) / qualifier | |||||||||||||||
point in time: 23 November 2021
| |||||||||||||||
Revision as of 23:13, 22 November 2021
Project Q3751766 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3751766 in France |
Statements
85,310 Euro
0 references
197,431.0 Euro
0 references
43.21 percent
0 references
21 December 2017
0 references
31 March 2019
0 references
PHARMATORY OY
0 references
65°2'59.10"N, 25°32'43.91"E
0 references
90620
0 references
Hankkeen pääasiallisena tavoitteena on liiketoiminnan kansainvälistäminen ja vankan jalansijan saavuttaminen USA:n markkinoilla. Tämä edellyttää toiminnalta FDA-vaatimusten mukaisuutta. Toimenpiteinä suunnitellaan ja toteutetaan analyysi- ja laadunvalvontalaboratorion laajennus ja uudistus koskien sekä laitekantaa että ohjelmistoja ja tietojärjestelmää. Uudistuksen tuloksena yritys pystyy tarjoamaan palveluita USA:n lääkemarkkinoille kyberturvallisuus huomioiden. (Finnish)
0 references
The main objective of the project is to internationalise the business and achieve a solid foothold in the US market. This requires FDA compliance. The measures will be to plan and implement the extension and renewal of the analytical and quality control laboratory for both the equipment base and the software and information system. As a result of the reform, the company will be able to provide services to the US pharmaceutical market, taking into account cybersecurity. (English)
23 November 2021
0 references